1. Removal of uncertainty of genetic risk |
-0.02 |
0.67 |
0.18 |
0.03 |
-0.73 |
-0.29 |
2. Provision of information for children |
0.07 |
0.79 |
0.28 |
0.10 |
-0.82 |
-0.39 |
3. Provision of information for other family members |
0.04 |
0.78 |
0.20 |
0.06 |
-0.79 |
-0.34 |
4. Provision of information for family planning |
-0.05 |
0.57 |
0.38 |
0.08 |
-0.76 |
-0.42 |
5. Access to increased surveillance and screening |
0.04 |
0.18 |
0.70 |
0.01 |
-0.33 |
-0.67 |
6. Access to clinical trials |
-0.05 |
0.22 |
0.43 |
-0.03 |
-0.26 |
-0.68 |
7. Greater choice of risk-reduction management |
-0.01 |
0.22 |
0.63 |
-0.01 |
-0.37 |
-0.71 |
8. Potential increase of life expectancy thanks to increased surveillance |
0.09 |
0.18 |
0.73 |
0.05 |
-0.35 |
-0.72 |
9. Psychological distress at being identified as a mutation carrier, due to increased risk of breast cancer |
0.45 |
0.34 |
-0.38 |
0.50 |
-0.07 |
0.04 |
10. Family conflict about disclosure of test results |
0.51 |
0.31 |
-0.28 |
0.57 |
-0.06 |
0.01 |
11. …limited employment opportunities |
0.76 |
0.00 |
0.05 |
0.75 |
-0.04 |
-0.02 |
12. …limited life insurance coverage |
0.82 |
-0.09 |
0.09 |
0.79 |
-0.02 |
0.00 |
13. …limited private health insurance coverage |
0.78 |
-0.08 |
0.14 |
0.76 |
-0.05 |
-0.03 |
14. …stigmatization as a “healthy ill” person |
0.78 |
0.06 |
-0.08 |
0.78 |
-0.03 |
0.03 |
Eigenvalue |
2.93 |
2.40 |
2.15 |
|
|
|
% variance |
20.94 |
17.11 |
15.33 |
|
|
|